Century Enka Share Price
608.90-7.75 (-1.26%)
+20.69% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | -6% | -15% |
| - | - | 4% | 52% |
| 9% | 6% | 13% | 22% |
| 5% | 5% | 5% | 7% |
Peer Comparison
Symbol
KPRMILL
PAGEIND
WELSPUNLIV
VTL
ARVIND
MANYAVAR
PGIL
SWANCORP
ICIL
GARFIBRES
CENTENKA
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,191.6 | ₹40225 Cr | 44.09 | 7.56 | 33.09 | ₹867 Cr |
| 36,175 | ₹40057 Cr | 53 | 172.86 | 775.02 | ₹764 Cr |
| 209.08 | ₹18957 Cr | 68.28 | 1.7 | 7.24 | ₹204 Cr |
| 600.25 | ₹17036 Cr | 20.09 | 10.7 | 45.91 | ₹745 Cr |
| 556.15 | ₹15414 Cr | 37.22 | 2.04 | 26.78 | ₹414 Cr |
| 593.8 | ₹13836 Cr | 35.86 | 3.32 | 22.96 | ₹376 Cr |
| 2,280.1 | ₹10757 Cr | 34.66 | 21.76 | 87.37 | ₹278 Cr |
| 281.6 | ₹8924 Cr | 39.91 | -1 | 11.1 | ₹274 Cr |
| 446.7 | ₹8668 Cr | 57.45 | 3.19 | 16.03 | ₹127 Cr |
| 795.95 | ₹7816 Cr | 37.21 | 6.62 | 25.24 | ₹199 Cr |
| 608.9 | ₹1349 Cr | 9.16 | 28.24 | 93.04 | ₹101 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹554 Cr | ₹484 Cr | ₹412 Cr | ₹409 Cr | ₹402 Cr | ₹444 Cr | ₹493 Cr | ₹536 Cr | ₹528 Cr | ₹469 Cr | ₹451 Cr | ₹396 Cr | ₹429 Cr | ₹473 Cr | ₹468 Cr | ₹563 Cr | ₹568 Cr |
| ₹8 Cr | ₹11 Cr | ₹9 Cr | ₹8 Cr | ₹14 Cr | ₹15 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹12 Cr | ₹9 Cr | ₹7 Cr | ₹4 Cr | ₹5 Cr | ₹3 Cr |
| ₹563 Cr | ₹495 Cr | ₹421 Cr | ₹417 Cr | ₹415 Cr | ₹459 Cr | ₹501 Cr | ₹544 Cr | ₹535 Cr | ₹476 Cr | ₹456 Cr | ₹408 Cr | ₹437 Cr | ₹480 Cr | ₹472 Cr | ₹568 Cr | ₹571 Cr |
| ₹483 Cr | ₹443 Cr | ₹384 Cr | ₹391 Cr | ₹395 Cr | ₹449 Cr | ₹481 Cr | ₹513 Cr | ₹500 Cr | ₹448 Cr | ₹445 Cr | ₹400 Cr | ₹418 Cr | ₹462 Cr | ₹458 Cr | ₹535 Cr | ₹517 Cr |
| ₹94 Cr | ₹66 Cr | ₹50 Cr | ₹40 Cr | ₹34 Cr | ₹24 Cr | ₹34 Cr | ₹45 Cr | ₹48 Cr | ₹41 Cr | ₹24 Cr | ₹21 Cr | ₹30 Cr | ₹30 Cr | ₹25 Cr | ₹43 Cr | ₹64 Cr |
| ₹46 L | ₹58 L | ₹76 L | ₹75 L | ₹80 L | ₹97 L | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹39 L | ₹37 L | ₹34 L |
| ₹79 Cr | ₹53 Cr | ₹32 Cr | ₹26 Cr | ₹19 Cr | ₹9 Cr | ₹19 Cr | ₹30 Cr | ₹34 Cr | ₹27 Cr | ₹10 Cr | ₹6 Cr | ₹18 Cr | ₹17 Cr | ₹14 Cr | ₹33 Cr | ₹54 Cr |
| ₹61 Cr | ₹40 Cr | ₹24 Cr | ₹23 Cr | ₹15 Cr | ₹7 Cr | ₹14 Cr | ₹22 Cr | ₹24 Cr | ₹20 Cr | ₹7 Cr | ₹5 Cr | ₹14 Cr | ₹15 Cr | ₹10 Cr | ₹26 Cr | ₹40 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| — | — | — | — |
| ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr |
| ₹1474 Cr | ₹1396 Cr | ₹1343 Cr | ₹1300 Cr |
| ₹1474 Cr | ₹1396 Cr | ₹1343 Cr | ₹1300 Cr |
| ₹1496 Cr | ₹1418 Cr | ₹1364 Cr | ₹1322 Cr |
| ₹6 Cr | ₹20 Cr | ₹34 Cr | ₹49 Cr |
| ₹93 Cr | ₹92 Cr | ₹82 Cr | ₹72 Cr |
| ₹26 Cr | ₹18 Cr | ₹18 Cr | ₹15 Cr |
| ₹13 Cr | ₹14 Cr | ₹12 Cr | ₹14 Cr |
| ₹138 Cr | ₹143 Cr | ₹146 Cr | ₹150 Cr |
| — | — | — | — |
| ₹172 Cr | ₹174 Cr | ₹129 Cr | ₹108 Cr |
| ₹40 Cr | ₹43 Cr | ₹41 Cr | ₹40 Cr |
| ₹0 | ₹10 L | ₹3 L | ₹18 L |
| ₹6 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹217 Cr | ₹221 Cr | ₹174 Cr | ₹151 Cr |
| ₹1851 Cr | ₹1782 Cr | ₹1684 Cr | ₹1623 Cr |
| ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| ₹20 Cr | ₹34 Cr | ₹49 Cr | ₹64 Cr |
| — | — | — | — |
| ₹1156 Cr | ₹1131 Cr | ₹1158 Cr | ₹948 Cr |
| ₹394 Cr | ₹343 Cr | ₹352 Cr | ₹304 Cr |
| ₹762 Cr | ₹788 Cr | ₹806 Cr | ₹645 Cr |
| ₹13 Cr | ₹13 Cr | ₹4 Cr | ₹106 Cr |
| ₹140 Cr | ₹71 Cr | ₹68 Cr | ₹37 Cr |
| ₹140 Cr | ₹71 Cr | ₹68 Cr | ₹37 Cr |
| ₹17 Cr | ₹11 Cr | ₹12 Cr | ₹14 Cr |
| ₹37 L | ₹24 L | ₹46 L | ₹8 L |
| ₹933 Cr | ₹884 Cr | ₹890 Cr | ₹802 Cr |
| — | — | — | — |
| ₹348 Cr | ₹338 Cr | ₹274 Cr | ₹307 Cr |
| ₹260 Cr | ₹315 Cr | ₹269 Cr | ₹243 Cr |
| ₹196 Cr | ₹175 Cr | ₹197 Cr | ₹217 Cr |
| ₹11 Cr | ₹5 Cr | ₹4 Cr | ₹16 Cr |
| ₹30 Cr | ₹17 Cr | ₹15 Cr | ₹7 Cr |
| ₹75 Cr | ₹47 Cr | ₹35 Cr | ₹30 Cr |
| ₹919 Cr | ₹897 Cr | ₹795 Cr | ₹820 Cr |
| ₹701 Cr | ₹676 Cr | ₹621 Cr | ₹669 Cr |
| ₹1851 Cr | ₹1782 Cr | ₹1684 Cr | ₹1623 Cr |
| ₹685 | ₹649 | ₹624 | ₹605 |
| ₹685 | ₹649 | ₹624 | ₹605 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ₹131 Cr | ₹92 Cr | ₹58 Cr | ₹118 Cr |
| ₹19 Cr | ₹31 Cr | ₹27 Cr | ₹27 Cr |
| -₹67 L | ₹14 Cr | ₹11 Cr | ₹105 Cr |
| ₹149 Cr | ₹137 Cr | ₹95 Cr | ₹250 Cr |
| ₹125 Cr | ₹118 Cr | ₹88 Cr | ₹219 Cr |
| -₹80 Cr | -₹76 Cr | -₹47 Cr | -₹251 Cr |
| -₹40 Cr | -₹42 Cr | -₹43 Cr | ₹29 Cr |
| ₹6 Cr | ₹8 L | -₹2 Cr | -₹3 Cr |
| ₹95 L | ₹87 L | ₹3 Cr | ₹6 Cr |
| ₹7 Cr | ₹95 L | ₹87 L | ₹3 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found